Bharat Parenterals Profit & Loss Annual

BSE: 541096 | NSE: - | ISIN: INE365Y01019 | Sector: Biotechnology & Drugs

1,681.00 +78.40 (4.89%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	257.36	217.98	212.01	204.64
Total Revenue	257.36	217.98	212.01	204.64
Costof Revenue Total	158.35	137.48	144.81	142.16
Gross Profit	99.01	80.50	67.20	62.48
Selling/ General/ Admin Expenses Total	22.78	18.00	34.78	33.05
Depreciation/ Amortization	9.02	5.88	6.55	5.91
Other Operating Expenses Total	53.86	42.59	3.18	3.17
Total Operating Expense	244.01	203.95	190.43	185.36
Operating Income	13.35	14.03	21.58	19.28
Interest Inc( Exp) Net- Non- Op Total	-32.20	-21.90	32.97	10.82
Other Net	8.59	11.74	3.73	6.76
Net Income Before Taxes	18.72	23.58	27.88	27.12
Provisionfor Income Taxes	8.21	7.83	7.06	6.81
Net Income After Taxes	10.51	15.75	20.81	20.32
Minority Interest	4.00	0.68	0.24	0.07
Net Income Before Extra Items	14.51	16.43	21.05	20.39
Net Income	14.51	16.43	21.05	20.39
Total Adjustmentsto Net Income	0.10	0.10	0.00	0.00
Income Availableto Com Excl Extra Ord	14.52	16.44	21.05	20.39
Income Availableto Com Incl Extra Ord	14.52	16.44	21.05	20.39
Diluted Net Income	14.52	16.44	21.05	20.39
Diluted Weighted Average Shares	0.58	0.58	0.57	0.57
Diluted EPS Excluding Extra Ord Items	24.94	28.40	36.67	35.59
DPS- Common Stock Primary Issue	1.00	0.75	-	-
Diluted Normalized EPS	24.94	28.40	37.64	35.57
Research Development	-	-	10.02	9.56
Interest Exp( Inc) Net- Operating Total	-	-	1.09	1.21
Gain( Loss)on Saleof Assets	-	-	-7.40	0.09